Literature DB >> 12751799

Vagal rebound during resolution of tearful crying among depressed and nondepressed individuals.

Jonathan Rottenberg1, Frank H Wilhelm, James J Gross, Ian H Gotlib.   

Abstract

Respiratory sinus arrhythmia (RSA) is an index of the vagal control of heart rate that is associated with emotion regulatory capacity. To examine RSA in depressed and nondepressed participants in the context of an emotion-regulatory challenge, we presented a sad film to induce crying, a behavior associated with heightened parasympathetic activation. We predicted that nondepressed persons who cried would show elevations in RSA during the onset and the resolution of crying. By contrast, we predicted that depressed individuals who cried would fail to exhibit increased RSA over the course of their crying episodes. As hypothesized, nondepressed participants exhibited RSA increases that accompanied the resolution of tearful crying, consistent with a homeostatic function for crying, whereas depressed subjects who cried did not exhibit increased RSA. Results suggest that the physiological self-regulatory mechanisms invoked by crying are compromised in depression.

Entities:  

Mesh:

Year:  2003        PMID: 12751799     DOI: 10.1111/1469-8986.00001

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  35 in total

1.  Respiratory sinus arrhythmia reactivity to a sad film predicts depression symptom improvement and symptomatic trajectory.

Authors:  Vanessa Panaite; Alexandra Cowden Hindash; Lauren M Bylsma; Brent J Small; Kristen Salomon; Jonathan Rottenberg
Journal:  Int J Psychophysiol       Date:  2015-12-08       Impact factor: 2.997

Review 2.  Polyvagal Theory and developmental psychopathology: emotion dysregulation and conduct problems from preschool to adolescence.

Authors:  Theodore P Beauchaine; Lisa Gatzke-Kopp; Hilary K Mead
Journal:  Biol Psychol       Date:  2006-10-12       Impact factor: 3.251

3.  Methodological issues in the quantification of respiratory sinus arrhythmia.

Authors:  John W Denver; Shawn F Reed; Stephen W Porges
Journal:  Biol Psychol       Date:  2006-10-25       Impact factor: 3.251

4.  Cry for her or cry with her: context-dependent dissociation of two modes of cinematic empathy reflected in network cohesion dynamics.

Authors:  Gal Raz; Yael Jacob; Tal Gonen; Yonatan Winetraub; Tamar Flash; Eyal Soreq; Talma Hendler
Journal:  Soc Cogn Affect Neurosci       Date:  2013-04-24       Impact factor: 3.436

5.  The effects of respiratory sinus arrhythmia on anger reactivity and persistence in major depression.

Authors:  Alissa J Ellis; Jason Shumake; Christopher G Beevers
Journal:  Psychophysiology       Date:  2016-07-12       Impact factor: 4.016

6.  Patterns of cortisol and alpha-amylase reactivity to psychosocial stress in maltreated women.

Authors:  Alyssa S Mielock; Matthew C Morris; Uma Rao
Journal:  J Affect Disord       Date:  2016-11-16       Impact factor: 4.839

Review 7.  Atypical reactivity of heart rate variability to stress and depression across development: Systematic review of the literature and directions for future research.

Authors:  Jessica L Hamilton; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2016-09-20

8.  Mothers' vagal regulation during the Still-Face Paradigm: normative reactivity and impact of depression symptoms.

Authors:  Julia E Oppenheimer; Jeffrey R Measelle; Heidemarie K Laurent; Jennifer C Ablow
Journal:  Infant Behav Dev       Date:  2013-02-28

9.  Respiratory sinus arrhythmia reactivity in current and remitted major depressive disorder.

Authors:  Lauren M Bylsma; Kristen Salomon; April Taylor-Clift; Bethany H Morris; Jonathan Rottenberg
Journal:  Psychosom Med       Date:  2013-12-23       Impact factor: 4.312

10.  High cardiac vagal control protects against future depressive symptoms under conditions of high social support.

Authors:  Henrik Hopp; Amanda J Shallcross; Brett Q Ford; Allison S Troy; Frank H Wilhelm; Iris B Mauss
Journal:  Biol Psychol       Date:  2013-01-23       Impact factor: 3.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.